How Candida Lipase Turns Xylitol into a New Prodrug?

In the realm of green chemistry, researchers have devised an elegant way to join two natural molecules: ferulic acid, famous for its antioxidant power, and xylitol, a plant‑based sweetener. Using Candida antarctica lipase B, an enzyme that acts like a tiny chemical “fork,” they created xylitol monoferulate (XMF). The reaction takes place in t‑amyl alcohol, an eco‑friendly solvent, without needing high temperatures or extreme pressure.

The process was fine‑tuned by adjusting temperature, reaction time, enzyme amount, and reactant ratio, achieving high yield and purity confirmed by advanced NMR spectroscopy (¹H, ¹³C, COSY, HSQC, HMBC). The result is a bifunctional molecule: it retains the anti‑inflammatory and neuroprotective traits of ferulic acid while inheriting the solubility and safety of xylitol.

This “green” synthesis not only cuts down on toxic chemicals but also paves the way for new prodrugs that are more stable and easily absorbed. In the future, XMF could be tested as an ingredient in dietary supplements or cosmetics, leveraging the blend of natural antioxidants and safe sweeteners. A significant step toward more sustainable chemistry and natural health solutions.

The selective esterification of ferulic acid with xylitol was carried out using Candida antarctica lipase B (CALB), a serine protease belonging to the lipase family. CALB features a large, flexible active site capable of accommodating bulky substrates such as xylitol, a five‑carbon polyol with three equatorial –OH groups. The reaction was performed in t‑amyl alcohol, an aprotic, low‑toxicity solvent that stabilizes the enzyme and minimizes ferulic acid auto‑hydrolysis.

Optimal conditions were identified through a factorial experimental design: 45 °C temperature, 24 h reaction time, FA:xylitol molar ratio 1:2, and enzyme loading 10 % w/w relative to total substrate. Under these parameters, conversion exceeded 90 % with an isolated yield of 85 %.

Structural characterization employed high‑resolution NMR spectroscopy. The ¹H‑NMR displayed the characteristic –CH₂‑O‑ferulate signal at δ 4.2 ppm, while ¹³C‑NMR confirmed ester formation with a carbonyl peak at δ 172 ppm. Two‑dimensional COSY and HSQC correlated xylitol protons with adjacent carbons, and HMBC revealed a long‑range connection between the ferulic carbonyl carbon and xylitol C‑1.

Biochemically, the ferulic moiety imparts antioxidant activity measurable by DPPH and ABTS assays, with an IC₅₀ lower than that of pure ferulic acid, likely due to enhanced aqueous solubility. Moreover, xylitol monoferulate exhibits higher thermal stability (Tₘ ≈ 210 °C) compared to ferulic acid alone (Tₘ ≈ 180 °C), suggesting steric protection from the polyol.

These findings pave the way for a library of bifunctional prodrugs based on other polyols (e.g., sorbitol, mannitol) and aromatic phenols, exploiting CALB’s versatility in green solvents. The synergy of enzymatic biocatalysis and low‑impact solvents offers a promising route for industrial production of high‑purity bioactive compounds, reducing toxic reagents and simplifying purification steps.